Sepulveda R, Kant A P
Clin Orthop Relat Res. 1985 Mar(193):68-74.
Chemonucleolysis is a procedure in which an enzyme is injected into the intervertebral disc for the purpose of alleviating sciatic pain. This has a reported success rate of 70%-90%. Of the failures, several will benefit from a classic lumbar laminectomy for removal of a free fragment in the spinal canal caused by either improper technique or inadequate enzyme activity. However, in a significant number of cases, the failure is related to either instability or the compression of the nerve roots in the neural foramen. Observations on 17 cases demonstrate that PLIF can relieve pain and other symptoms in cases of failed chemonucleolysis.
化学髓核溶解术是一种将酶注射到椎间盘以减轻坐骨神经痛的手术。据报道,其成功率为70%-90%。在失败的病例中,有几例将受益于经典的腰椎椎板切除术,以清除因技术不当或酶活性不足导致的椎管内游离碎片。然而,在相当多的病例中,失败与不稳定或神经孔内神经根受压有关。对17例病例的观察表明,后路腰椎椎间融合术(PLIF)可缓解化学髓核溶解术失败病例的疼痛和其他症状。